XBiotech Inc. ( XBIT) - Key Metrics
XBIT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
XBIT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
XBIT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -12.52% | ? |
| 2025Q4 | -31.55% | ? |
| 2025Q3 | -5.39% | ? |
| 2025Q2 | -6.67% | ? |
| 2025Q1 | -6.90% | ? |
XBIT
Price: $2.31
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.49 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 35800
Ebitda: -47.9 millionMarket Capitalization: 72.3 million